Diabetes Advocacy Alliance Diabetes Advocacy Alliance Diabetes Advocacy Alliance

Latest News

AADE, ADA, AND release new position statement on diabetes self-management education and support at ADA Scientific Sessions.

Click Here for More Info

USPSTF evidence review for diabetes screening and an editorial that makes a strong case for screening for prediabetes and undiagnosed type 2 diabetes published in June 2, 2015 issue of Annals of Internal Medicine.

Click Here for More Info

New study in Journal of Medical Internet Research shows positive two-year data for Omada Health’s online Prevent program for type 2 diabetes prevention.

Click Here for More Info

Member Profile

Novo Nordisk Inc.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit www.novonordisk.com.

Click Here to Read More

The Diabetes Advocacy AllianceTM is working to increase awareness of, and action on, the diabetes epidemic among legislators and policymakers.  We are a diverse group of patient advocacy organizations, professional societies, trade associations and corporations, sharing a common goal to defeat diabetes.  Explore our site to learn more about what's on the front burner in our communications with Capitol Hill and the Administration. The Diabetes Advocacy Alliance™ is working to increase awareness of, and action on, the diabetes epidemic among legislators and policymakers. We are a diverse group of patient advocacy organizations, professional societies, trade associations and corporations, sharing a common goal to defeat diabetes. Explore our site to learn more about what's on the front burner in our communications with Capitol Hill and the Administration.

DAA Priorities for 2015

The Diabetes Advocacy Alliance (DAA) has public policy and legislative priorities in three areas: Prevention of type 2 diabetes; improved screening and detection of those adults with prediabetes and undiagnosed diabetes; and improved care for people whose diabetes has been diagnosed. A summary of DAA and DAA member priorities in diabetes is presented in this document: Advocacy Priorities in 2015.